Lamia Abdouni
Psychiatric/Mental Health · Chandler, AZNPI 1679928790
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,121 and has fallen 78.2% since, to $462 in 2025. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 241 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$674
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$619
- Sunovion Pharmaceuticals Inc.$554
- Otsuka America Pharmaceutical, Inc.$543
- Johnson & Johnson$332
- Vanda Pharmaceuticals Inc.$260
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,69099%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $674 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $619 |
| Sunovion Pharmaceuticals Inc. | 39 | $554 |
| Otsuka America Pharmaceutical, Inc. | 27 | $543 |
| Johnson & Johnson | 12 | $332 |
| Vanda Pharmaceuticals Inc. | 12 | $260 |
| Ironshore Pharmaceuticals Inc. | 16 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $214 |
| Alkermes, Inc. | 3 | $208 |
| Lundbeck LLC | 9 | $152 |
| Bausch Health US, LLC | 8 | $143 |
| Teva Pharmaceuticals USA, Inc. | 2 | $131 |
| Eisai Inc. | 6 | $104 |
| Alfasigma USA, Inc. | 6 | $97 |
| Supernus Pharmaceuticals, Inc. | 5 | $93 |
| Almatica Pharma LLC | 4 | $92 |
| Tris Pharma Inc | 4 | $75 |
| Corium, LLC | 5 | $70 |
| Noven Therapeutics, LLC | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Neos Therapeutics, LP | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$441
- CAPLYTA$330
- Austedo XR$117
- ARISTADA INITIO$110
- REXULTI$108
- INVEGA SUSTENNA$101
How this compares
$4,737 in reported general payments places this provider in the 90th percentile of 1,230 psychiatric/mental health providers in Arizona.
Other psychiatric/mental health in Chandler
- Amanda FitzgeraldChandler$10K
- Ruth FluckerChandler$6K
- Devin SouthworthChandler$5K
- Elizabeth ElliottPhoenix$363K
- Diane StrickerGilbert$281K
- Russell HorningPhoenix$254K
- Stacy UnderwoodMesa$252K
- Brett LeifsonScottsdale$90K
- Claire ReecePhoenix$88K
- Bryan LazaroScottsdale$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.